Characteristics of 5-aminolaevulinic acid-induced protoporphyrin IX fluorescence in human skin in vivo

Photodermatology Photoimmunology and Photomedicine

Volumn 22, Issue 2, 2006, Pages 105-110

  Ibbotson, Sally H ^a   Jong, C ^a   Lesar, A ^a   Ferguson, J S ^a   Padgett, M ^b   O'Dwyer, M ^b   Barnetson, R ^c   Ferguson, J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

5 aminolaevulinic acid (ALA); Fluorescence; Photodynamic therapy (PDT); Protoporphyrin IX (PpIX)

Indexed keywords

AMINOLEVULINIC ACID; PROTOPORPHYRIN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG METABOLISM; DRUG UPTAKE; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; MALE; NORMAL HUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SPECTROFLUOROMETRY; STRATUM CORNEUM; VOLUNTEER;

ADULT; AMINOLEVULINIC ACID; FEMALE; FLUORESCENCE; HUMANS; MALE; MIDDLE AGED; PROTOPORPHYRINS; REFERENCE VALUES; SKIN;

EID: 33745934498     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2006.00202.x     Document Type: Article

References (11)

1. Morton CA, Brown SB, Collins S, et al. Guidelines for topical photodynamic therapy; report of a workshop of the British Photodermatology Group. Br J Dermatol 2002; 146: 552-567.
2. Clark C, Dawe RS, Moseley H, Ferguson J, Ibbotson SH. The characteristics of erythema induced by topical 5-aminolaevulinic acid photodynamic therapy. Photoderm Photoimmunol Photomed 2004; 20: 105-107.
3. Fritsch C, Lehmann P, Stahl W., et al. Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of δ-aminolaevulinic acid. Br J Cancer 1999; 79: 1603-1608.
4. Goff BA, Bachor R, Kollias N, Hasan T. Effects of photodynamic therapy with topical application of 5-aminolevulinic acid on normal skin of hairless guinea pigs. J Photochem Photobiol B: Biol 1992; 15: 239-251.
5. Van den Akker, Iani V, Star WM, Sterenborg HJCM, Moan J. Systemic component of protoporphyrin IX production in nude mouse skin upon topical application of aminolevulinic acid depends on the application conditions. Photochem Photobiol 2002; 75: 172-177.
6. Rhodes LE, Tsoukas MM, Anderson RR, Kollias N. Iontophoretic delivery of ALA provides a quantitative model for ALA pharmacokinetics and PpIX phototoxicity in human skin. J Invest Dermatol 1997; 108: 87-91.
7. Farr PM, Diffey BL. Quantitative studies on cutaneous erythema induced by ultraviolet radiation. Br J Dermatol 1984; 111: 673-682.
8. Waterston K, Naysmith L, Rees JL. Physiological variation in the erythemal response to ultraviolet radiation and photoadaptation. J Invest Dermatol 2004; 123: 958-964.
9. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience. J Photochem Photobiol 1990; 6: 143-148.
10. Von Beckerath M, Juzenas P, Ma L-W, Iani V, Lofgren L, Moan J. The influence of UV exposure on 5-aminolevulinic acid-induced protoporphyrin IX production in skin. Photochem Photobiol 2001; 74: 825-828.
11. Morris SD, Mason NG, Elder GH, Hawk JL, Sarkany RP. Ferrochelatase gene polymorphism analysis for accurate genetic counselling in erythropoietic protoporphyria. Br J Dermatol 2002; 147: 572-574.